MADE POSSIBLE BY:
MADE POSSIBLE BY:
Singapore skyline

Critical Aspects of Investigational New Drug (IND) Applications: An Interview with Glenn Petrie, Ph.D

EAG Laboratories is a global scientific services company providing testing, analytical and characterization services to clients across a vast array of technology- and life-science-related industries. The company has recently made significant investments to support its...
Guell park in Barcelona

Anna Sureda MD PhD: “An Intelligent Way to Deliver High Doses of a Very...

Surrounded by fantastical and modernist landmarks designed by Antoni Gaudí, Barcelona, in the northeast of Spain, is a surreal wonderland where mansions look like dragons... or giant ice-cream sundaes, the Museu Picasso and Fundació Joan...
Woman Having Chemotherapy With Nurse Using Digital Tablet

INSIGHT-MM Study Designed to Advance Real-world Understanding of Multiple Myeloma

In late Augustus 2016 Takeda Oncology announced that the INSIGHT-MM, the company's global non-interventional, observational multiple myeloma study, is now enrolling patients. The study aims to enroll 5,000 patients over three years with a...

Goodwin Biotechnology: Mastering Novel Conjugation Approaches

Often described as target-seeking molecular missiles with a lethal warhead, antibody-drug conjugates have, over the last 15 years, shown to have staying power. With two approved antibody-drug conjugates currently available and more than 50...

Q&A – an Interview with Lonza’s Laurent Ducry

Antibody-drug Conjugates or ADCs are among the most exciting drug developments of the last decade. The combination of potent, small molecule drugs with the highly target specificity of monoclonal antibodies allows sensitive discrimination between...